Publications by authors named "Rod A Porter"

Claim this Profile
D
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.
Romano Di Fabio, Annalisa Pellacani, Stefania Faedo, Adelheid Roth, Laura Piccoli, Rod A Porter

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands.
Hugh J Herdon, Jennifer C Roberts, Steve Coulton, Rod A Porter

Neuropharmacology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test.
Mikhail Kalinichev, Kathryn R Starr, Simon Teague, Andrea M Bradford, Rod A Porter

Brain Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
Scott G Summerfield, Kevin Read, David J Begley, Tanja Obradovic, Ismael J Hidalgo, Rod A Porter

J Pharmacol Exp Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.
Christopher J Langmead, Jeffrey C Jerman, Stephen J Brough, Claire Scott, Rod A Porter

Br J Pharmacol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis